Symbol:
Bcl7b
Name:
BAF chromatin remodeling complex subunit BCL7B
RGD ID:
1597090
Description:
Predicted to be part of SWI/SNF complex. Orthologous to human BCL7B (BAF chromatin remodeling complex subunit BCL7B); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
B-cell CLL/lymphoma 7 protein family member B; B-cell CLL/lymphoma 7B; BCL tumor suppressor 7B; BCL7B, BAF complex component; LOC368001; similar to B-cell CLL/lymphoma 7B
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 27,133,412 - 27,146,631 (-) NCBI GRCr8 mRatBN7.2 12 21,496,860 - 21,510,079 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 21,496,856 - 21,510,202 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 22,638,494 - 22,651,869 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 23,250,819 - 23,264,194 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 22,317,282 - 22,330,657 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 24,543,748 - 24,557,093 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 24,543,759 - 24,556,976 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 26,541,051 - 26,554,396 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 22,651,275 - 22,656,141 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 12 23,259,412 - 23,272,757 (-) NCBI Celera Cytogenetic Map 12 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Bcl7b Rat 1,2-dimethylhydrazine increases expression ISO Bcl7b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of BCL7B mRNA CTD PMID:22206623 Bcl7b Rat 17alpha-ethynylestradiol affects expression ISO Bcl7b (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of BCL7B mRNA CTD PMID:17555576 Bcl7b Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL7B mRNA CTD PMID:21215274 Bcl7b Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL7B mRNA CTD PMID:33387578 Bcl7b Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl7b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL7B mRNA CTD PMID:21570461 and PMID:24680724 Bcl7b Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO BCL7B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL7B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7B mRNA CTD PMID:28628672 Bcl7b Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BCL7B mRNA CTD PMID:36041667 Bcl7b Rat antimycin A decreases expression ISO BCL7B (Homo sapiens) 6480464 Antimycin A results in decreased expression of BCL7B mRNA CTD PMID:33512557 Bcl7b Rat arsane affects methylation ISO BCL7B (Homo sapiens) 6480464 Arsenic affects the methylation of BCL7B gene CTD PMID:25304211 Bcl7b Rat arsenic atom affects methylation ISO BCL7B (Homo sapiens) 6480464 Arsenic affects the methylation of BCL7B gene CTD PMID:25304211 Bcl7b Rat benzo[a]pyrene multiple interactions ISO Bcl7b (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 Bcl7b Rat benzo[b]fluoranthene multiple interactions ISO Bcl7b (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 Bcl7b Rat Benzo[k]fluoranthene increases expression ISO Bcl7b (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of BCL7B mRNA CTD PMID:26377693 Bcl7b Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL7B mRNA CTD PMID:25181051 Bcl7b Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BCL7B mRNA CTD PMID:36041667 Bcl7b Rat bisphenol A decreases expression ISO Bcl7b (Mus musculus) 6480464 bisphenol A results in decreased expression of BCL7B mRNA CTD PMID:33221593 Bcl7b Rat bisphenol A multiple interactions ISO BCL7B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL7B mRNA CTD PMID:28628672 Bcl7b Rat bisphenol F multiple interactions ISO BCL7B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7B mRNA CTD PMID:28628672 Bcl7b Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BCL7B mRNA CTD PMID:36041667 Bcl7b Rat cadmium atom multiple interactions ISO BCL7B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL7B mRNA CTD PMID:35301059 Bcl7b Rat cadmium dichloride multiple interactions ISO BCL7B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BCL7B mRNA CTD PMID:35301059 Bcl7b Rat caffeine affects phosphorylation ISO BCL7B (Homo sapiens) 6480464 Caffeine affects the phosphorylation of BCL7B protein CTD PMID:35688186 Bcl7b Rat cannabidiol decreases expression ISO BCL7B (Homo sapiens) 6480464 Cannabidiol results in decreased expression of BCL7B mRNA CTD PMID:27918106 and PMID:27932991 Bcl7b Rat carbon nanotube decreases expression ISO Bcl7b (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of BCL7B mRNA CTD PMID:25554681 Bcl7b Rat chlorpyrifos increases expression ISO Bcl7b (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BCL7B mRNA CTD PMID:37019170 Bcl7b Rat chrysene multiple interactions ISO Bcl7b (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 Bcl7b Rat coumarin increases phosphorylation ISO BCL7B (Homo sapiens) 6480464 coumarin results in increased phosphorylation of BCL7B protein CTD PMID:35688186 Bcl7b Rat dexamethasone multiple interactions ISO BCL7B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL7B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7B mRNA CTD PMID:28628672 Bcl7b Rat elemental selenium increases expression ISO BCL7B (Homo sapiens) 6480464 Selenium results in increased expression of BCL7B mRNA CTD PMID:19244175 Bcl7b Rat FR900359 increases phosphorylation ISO BCL7B (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of BCL7B protein CTD PMID:37730182 Bcl7b Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL7B mRNA CTD PMID:33387578 Bcl7b Rat glycidyl methacrylate decreases expression ISO BCL7B (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of BCL7B protein CTD PMID:36641056 Bcl7b Rat indometacin multiple interactions ISO BCL7B (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL7B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7B mRNA CTD PMID:28628672 Bcl7b Rat inulin multiple interactions ISO Bcl7b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BCL7B mRNA CTD PMID:36331819 Bcl7b Rat ivermectin decreases expression ISO BCL7B (Homo sapiens) 6480464 Ivermectin results in decreased expression of BCL7B protein CTD PMID:32959892 Bcl7b Rat nitrates multiple interactions ISO Bcl7b (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BCL7B mRNA CTD PMID:35964746 Bcl7b Rat p-menthan-3-ol increases expression ISO BCL7B (Homo sapiens) 6480464 Menthol results in increased expression of BCL7B mRNA CTD PMID:26760959 Bcl7b Rat paracetamol increases expression ISO BCL7B (Homo sapiens) 6480464 Acetaminophen results in increased expression of BCL7B mRNA CTD PMID:22230336 Bcl7b Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL7B mRNA CTD PMID:33387578 Bcl7b Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Bcl7b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BCL7B mRNA CTD PMID:36331819 Bcl7b Rat rotenone decreases expression ISO BCL7B (Homo sapiens) 6480464 Rotenone results in decreased expression of BCL7B mRNA CTD PMID:33512557 Bcl7b Rat selenium atom increases expression ISO BCL7B (Homo sapiens) 6480464 Selenium results in increased expression of BCL7B mRNA CTD PMID:19244175 Bcl7b Rat sodium dichromate decreases expression ISO Bcl7b (Mus musculus) 6480464 sodium bichromate results in decreased expression of BCL7B mRNA CTD PMID:31558096 Bcl7b Rat sunitinib increases expression ISO BCL7B (Homo sapiens) 6480464 Sunitinib results in increased expression of BCL7B mRNA CTD PMID:31533062 Bcl7b Rat tamoxifen affects expression ISO Bcl7b (Mus musculus) 6480464 Tamoxifen affects the expression of BCL7B mRNA CTD PMID:17555576 Bcl7b Rat tebufenpyrad decreases expression ISO BCL7B (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of BCL7B mRNA CTD PMID:33512557 Bcl7b Rat tetraphene multiple interactions ISO Bcl7b (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA CTD PMID:27858113 Bcl7b Rat titanium dioxide decreases methylation ISO Bcl7b (Mus musculus) 6480464 titanium dioxide results in decreased methylation of BCL7B promoter CTD PMID:35295148 Bcl7b Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCL7B mRNA CTD PMID:33387578 Bcl7b Rat triphenyl phosphate affects expression ISO BCL7B (Homo sapiens) 6480464 triphenyl phosphate affects the expression of BCL7B mRNA CTD PMID:37042841 Bcl7b Rat urethane increases expression ISO BCL7B (Homo sapiens) 6480464 Urethane results in increased expression of BCL7B mRNA CTD PMID:28818685 Bcl7b Rat valproic acid decreases expression ISO Bcl7b (Mus musculus) 6480464 Valproic Acid results in decreased expression of BCL7B mRNA CTD PMID:21427059 Bcl7b Rat valproic acid affects expression ISO BCL7B (Homo sapiens) 6480464 Valproic Acid affects the expression of BCL7B mRNA CTD PMID:25979313 Bcl7b Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BCL7B mRNA CTD PMID:23034163
Bcl7b Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 27,133,412 - 27,146,631 (-) NCBI GRCr8 mRatBN7.2 12 21,496,860 - 21,510,079 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 21,496,856 - 21,510,202 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 22,638,494 - 22,651,869 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 23,250,819 - 23,264,194 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 22,317,282 - 22,330,657 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 24,543,748 - 24,557,093 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 24,543,759 - 24,556,976 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 26,541,051 - 26,554,396 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 22,651,275 - 22,656,141 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 12 23,259,412 - 23,272,757 (-) NCBI Celera Cytogenetic Map 12 q12 NCBI
BCL7B Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 73,536,356 - 73,557,690 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 73,536,356 - 73,557,690 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 72,950,686 - 72,972,020 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 72,588,622 - 72,609,960 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 7 72,395,336 - 72,416,675 NCBI Celera 7 68,428,601 - 68,449,940 (-) NCBI Celera Cytogenetic Map 7 q11.23 NCBI HuRef 7 68,832,300 - 68,853,680 (-) NCBI HuRef CHM1_1 7 73,096,104 - 73,117,479 (-) NCBI CHM1_1 T2T-CHM13v2.0 7 74,736,839 - 74,758,190 (-) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 72,283,755 - 72,305,137 (-) NCBI
Bcl7b Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 135,197,226 - 135,210,706 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 135,197,137 - 135,210,709 (+) Ensembl GRCm39 Ensembl GRCm38 5 135,168,372 - 135,181,852 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 135,168,283 - 135,181,855 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 135,644,242 - 135,657,722 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 135,453,119 - 135,466,472 (+) NCBI MGSCv36 mm8 Celera 5 132,179,566 - 132,193,046 (+) NCBI Celera Cytogenetic Map 5 G2 NCBI cM Map 5 75.04 NCBI
Bcl7b Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955456 14,148,868 - 14,167,653 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955456 14,149,484 - 14,166,753 (+) NCBI ChiLan1.0 ChiLan1.0
BCL7B Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 91,344,072 - 91,365,509 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 139,608,747 - 139,630,142 (+) NCBI NHGRI_mPanPan1 PanPan1.1 7 80,688,360 - 80,712,657 (-) NCBI panpan1.1 PanPan1.1 panPan2
BCL7B Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 6 6,680,619 - 6,701,601 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 6 6,680,735 - 6,700,639 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 6 8,377,928 - 8,398,893 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 6 6,495,597 - 6,516,598 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 6 6,471,231 - 6,516,598 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 6 6,485,070 - 6,506,023 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 6 6,432,831 - 6,453,818 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 6 6,596,500 - 6,617,465 (+) NCBI UU_Cfam_GSD_1.0
Bcl7b Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 131,214,623 - 131,242,920 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936543 2,799,571 - 2,821,956 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936543 2,793,098 - 2,821,933 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
BCL7B Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 10,850,354 - 10,869,288 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 10,850,347 - 10,887,485 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 10,550,010 - 10,587,144 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
BCL7B Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 28 9,498,053 - 9,527,419 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 28 9,498,161 - 9,526,542 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666070 6,952,624 - 6,978,801 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Bcl7b
.
Predicted Target Of
Count of predictions: 226 Count of miRNA genes: 145 Interacting mature miRNAs: 161 Transcripts: ENSRNOT00000041798, ENSRNOT00000067945, ENSRNOT00000074083 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631560 Apr1 Acute phase response QTL 1 6.1 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 19144362 46669029 Rat 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 3.5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 14 nervous system integrity trait (VT:0010566) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) 12 19610870 46669029 Rat 9590147 Scort7 Serum corticosterone level QTL 7 13.61 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 12 1 42110980 Rat 1549829 Scl48 Serum cholesterol level QTL 48 5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 12 9603277 46669029 Rat 61331 Eau2 Experimental allergic uveoretinitis QTL 2 0.0005 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 12 8525423 28064601 Rat 737822 Alc10 Alcohol consumption QTL 10 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 19610870 40218516 Rat 2293684 Bmd26 Bone mineral density QTL 26 4.4 0.0002 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 12 15872653 32974238 Rat 6893681 Bw109 Body weight QTL 109 2.3 0.004 body mass (VT:0001259) body weight (CMO:0000012) 12 1 23297788 Rat 1302792 Scl21 Serum cholesterol level QTL 21 3.8 0.0011 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 12 7196730 46669029 Rat 1598855 Bp294 Blood pressure QTL 294 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 1 34851688 Rat 10755457 Coatc14 Coat color QTL 14 0.01759 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 12 1 22591684 Rat 1331761 Bp218 Blood pressure QTL 218 2.973 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 45055165 Rat 8694179 Bw150 Body weight QTL 150 2.9 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411545 Bw128 Body weight QTL 128 5.2 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411547 Bw129 Body weight QTL 129 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 5564495 46669029 Rat 1300157 Rf21 Renal function QTL 21 4.4 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 12 9318216 32103380 Rat 737979 Pia22 Pristane induced arthritis QTL 22 53.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 1 44465750 Rat 1298081 Cia25 Collagen induced arthritis QTL 25 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610889 35682913 Rat 2300186 Bmd59 Bone mineral density QTL 59 7.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 12 10474137 46669029 Rat 7411660 Foco28 Food consumption QTL 28 10.9 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 1331755 Bp219 Blood pressure QTL 219 3.041 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 28064557 Rat 70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 3.72 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 19835789 38193007 Rat 2306789 Ean6 Experimental allergic neuritis QTL 6 4.9 nervous system integrity trait (VT:0010566) experimental autoimmune neuritis severity score (CMO:0001528) 12 19610870 24139202 Rat 7411641 Foco19 Food consumption QTL 19 27.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 7411643 Foco20 Food consumption QTL 20 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 20328819 46669029 Rat 5684888 Pia42 Pristane induced arthritis QTL 42 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610870 42828880 Rat 1549912 Bp268 Blood pressure QTL 268 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 13182736 46669029 Rat 2302060 Pia37 Pristane induced arthritis QTL 37 6.1 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 13198157 46669029 Rat 1641928 Alcrsp5 Alcohol response QTL 5 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 12 12812385 46669029 Rat 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564498 46669029 Rat 10059594 Kidm46 Kidney mass QTL 46 3.79 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 12 6107579 46669029 Rat 1581516 Cm56 Cardiac mass QTL 56 4.2 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 12 1 29333307 Rat 9590086 Insglur6 Insulin/glucose ratio QTL 6 18.97 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 12 1 42110980 Rat 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 1549902 Bp269 Blood pressure QTL 269 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 13182736 46669029 Rat 61404 Bw120 Body weight QTL 120 5.1 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 12 12351619 46669029 Rat 1331786 Kidm11 Kidney mass QTL 11 3.571 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 12 11073825 24234895 Rat 2293699 Bss49 Bone structure and strength QTL 49 5.61 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 12 10474137 46669029 Rat 634351 Apr5 Acute phase response QTL 5 6.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 12 1 44503507 Rat 634350 Apr4 Acute phase response QTL 4 6 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 1172005 46172005 Rat 61416 Pia4 Pristane induced arthritis QTL 4 8.4 joint integrity trait (VT:0010548) arthritic paw count (CMO:0001460) 12 13635523 30827399 Rat 631521 Pia12 Pristane induced arthritis QTL 12 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 20259417 23672083 Rat 7387292 Kidm42 Kidney mass QTL 42 3.03 0.0004 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 12 1 36247923 Rat 61421 Cia12 Collagen induced arthritis QTL 12 4.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 13635523 35682913 Rat 2303569 Gluco44 Glucose level QTL 44 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 12812385 46669029 Rat 7411586 Foco5 Food consumption QTL 5 5.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 2303575 Insul14 Insulin level QTL 14 4 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 12 1 42450532 Rat 7411588 Foco6 Food consumption QTL 6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2302042 Pia38 Pristane induced arthritis QTL 38 3.5 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 1 44503507 Rat 7411595 Foco9 Food consumption QTL 9 4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 7411597 Foco10 Food consumption QTL 10 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2293086 Iddm30 Insulin dependent diabetes mellitus QTL 30 3.82 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 8449490 28302290 Rat 631543 Bp83 Blood pressure QTL 83 5.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 15550826 38478808 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000041798 ⟹ ENSRNOP00000046167
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 21,496,856 - 21,510,202 (-) Ensembl Rnor_6.0 Ensembl 12 24,543,759 - 24,556,976 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000117047 ⟹ ENSRNOP00000097033
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 21,496,856 - 21,510,202 (-) Ensembl
RefSeq Acc Id:
NM_001420935 ⟹ NP_001407864
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 27,133,412 - 27,146,631 (-) NCBI mRatBN7.2 12 21,496,860 - 21,510,079 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000046167 ⟸ ENSRNOT00000041798
Ensembl Acc Id:
ENSRNOP00000097033 ⟸ ENSRNOT00000117047
RefSeq Acc Id:
NP_001407864 ⟸ NM_001420935
- UniProtKB:
A0A9K3Y829 (UniProtKB/TrEMBL), B1H245 (UniProtKB/TrEMBL), F1LP28 (UniProtKB/TrEMBL)
RGD ID: 13698557 Promoter ID: EPDNEW_R9082 Type: initiation region Name: Bcl7b_1 Description: BCL tumor suppressor 7B SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 12 24,556,971 - 24,557,031 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2019-04-02
Bcl7b
BAF chromatin remodeling complex subunit BCL7B
Bcl7b
BCL7B, BAF complex component
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2018-11-09
Bcl7b
BCL7B, BAF complex component
Bcl7b
BCL tumor suppressor 7B
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2016-07-13
Bcl7b
BCL tumor suppressor 7B
Bcl7b
B-cell CLL/lymphoma 7B
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-03-05
Bcl7b
B-cell CLL/lymphoma 7B
LOC368001
similar to B-cell CLL/lymphoma 7B
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-11-20
LOC368001
similar to B-cell CLL/lymphoma 7B
Symbol and Name status set to provisional
70820 PROVISIONAL
